Application 020098

Type
NDA
Sponsor
ABBVIE

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001MIVACRONMIVACURIUM CHLORIDESOLUTION;INTRAVENOUSEQ 2MG BASE/ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo
002MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINERMIVACURIUM CHLORIDEINJECTABLE;INJECTIONEQ 0.5MG BASE/MLNoNo
003MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINERMIVACURIUM CHLORIDEINJECTABLE;INJECTIONEQ 50MG BASE/100MLNoNo
004MIVACRONMIVACURIUM CHLORIDESOLUTION;INTRAVENOUSEQ 10MG BASE/5ML (EQ 2MG BASE/ML)YesNo
005MIVACRONMIVACURIUM CHLORIDESOLUTION;INTRAVENOUSEQ 20MG BASE/10ML (EQ 2MG BASE/ML)YesNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 5 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N020098-001MIVACRONMIVACURIUM CHLORIDEEQ 2MG BASE/ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SOLUTION / INTRAVENOUSRLD1992-01-22
N020098-002MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINERMIVACURIUM CHLORIDEEQ 0.5MG BASE/MLINJECTABLE / INJECTION1992-01-22
N020098-003MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINERMIVACURIUM CHLORIDEEQ 50MG BASE/100MLINJECTABLE / INJECTION1992-01-22
N020098-004MIVACRONMIVACURIUM CHLORIDEEQ 10MG BASE/5ML (EQ 2MG BASE/ML)SOLUTION / INTRAVENOUSRLD1992-01-22
N020098-005MIVACRONMIVACURIUM CHLORIDEEQ 20MG BASE/10ML (EQ 2MG BASE/ML)SOLUTION / INTRAVENOUSRLD1992-01-22

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 4 of 6 · 220 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2021-03-12 10:30 UTC2021-03N020098-001MIVACRONEQ 2MG BASE/ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**SOLUTION / INTRAVENOUSRLD1992-01-225aa47cf7b7d7…
2021-03-12 10:30 UTC2021-03N020098-002MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINEREQ 0.5MG BASE/MLINJECTABLE / INJECTION1992-01-225aa47cf7b7d7…
2021-03-12 10:30 UTC2021-03N020098-003MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINEREQ 50MG BASE/100MLINJECTABLE / INJECTION1992-01-225aa47cf7b7d7…
2021-03-12 10:30 UTC2021-03N020098-004MIVACRONEQ 10MG BASE/5ML (EQ 2MG BASE/ML)SOLUTION / INTRAVENOUSRLD1992-01-225aa47cf7b7d7…
2021-03-12 10:30 UTC2021-03N020098-005MIVACRONEQ 20MG BASE/10ML (EQ 2MG BASE/ML)SOLUTION / INTRAVENOUSRLD1992-01-225aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N020098-001MIVACRONEQ 2MG BASE/ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**SOLUTION / INTRAVENOUSRLD1992-01-228869cabd3fbd…
2020-12-22 03:56 UTC2020-12N020098-002MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINEREQ 0.5MG BASE/MLINJECTABLE / INJECTION1992-01-228869cabd3fbd…
2020-12-22 03:56 UTC2020-12N020098-003MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINEREQ 50MG BASE/100MLINJECTABLE / INJECTION1992-01-228869cabd3fbd…
2020-12-22 03:56 UTC2020-12N020098-004MIVACRONEQ 10MG BASE/5ML (EQ 2MG BASE/ML)SOLUTION / INTRAVENOUSRLD1992-01-228869cabd3fbd…
2020-12-22 03:56 UTC2020-12N020098-005MIVACRONEQ 20MG BASE/10ML (EQ 2MG BASE/ML)SOLUTION / INTRAVENOUSRLD1992-01-228869cabd3fbd…
2020-11-12 02:37 UTC2020-11N020098-001MIVACRONEQ 2MG BASE/ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**SOLUTION / INTRAVENOUSRLD1992-01-22c0c555d07b60…
2020-11-12 02:37 UTC2020-11N020098-002MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINEREQ 0.5MG BASE/MLINJECTABLE / INJECTION1992-01-22c0c555d07b60…
2020-11-12 02:37 UTC2020-11N020098-003MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINEREQ 50MG BASE/100MLINJECTABLE / INJECTION1992-01-22c0c555d07b60…
2020-11-12 02:37 UTC2020-11N020098-004MIVACRONEQ 10MG BASE/5ML (EQ 2MG BASE/ML)SOLUTION / INTRAVENOUSRLD1992-01-22c0c555d07b60…
2020-11-12 02:37 UTC2020-11N020098-005MIVACRONEQ 20MG BASE/10ML (EQ 2MG BASE/ML)SOLUTION / INTRAVENOUSRLD1992-01-22c0c555d07b60…
2019-12-14 00:12 UTC2019-12N020098-001MIVACRONEQ 2MG BASE/ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**SOLUTION / INTRAVENOUSRLD1992-01-223f01610625f2…
2019-12-14 00:12 UTC2019-12N020098-002MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINEREQ 0.5MG BASE/MLINJECTABLE / INJECTION1992-01-223f01610625f2…
2019-12-14 00:12 UTC2019-12N020098-003MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINEREQ 50MG BASE/100MLINJECTABLE / INJECTION1992-01-223f01610625f2…
2019-12-14 00:12 UTC2019-12N020098-004MIVACRONEQ 10MG BASE/5ML (EQ 2MG BASE/ML)SOLUTION / INTRAVENOUSRLD1992-01-223f01610625f2…
2019-12-14 00:12 UTC2019-12N020098-005MIVACRONEQ 20MG BASE/10ML (EQ 2MG BASE/ML)SOLUTION / INTRAVENOUSRLD1992-01-223f01610625f2…
2019-09-15 20:21 UTC2019-09N020098-001MIVACRONEQ 2MG BASE/ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**SOLUTION / INTRAVENOUSRLD1992-01-22b00525d2431f…
2019-09-15 20:21 UTC2019-09N020098-002MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINEREQ 0.5MG BASE/MLINJECTABLE / INJECTION1992-01-22b00525d2431f…
2019-09-15 20:21 UTC2019-09N020098-003MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINEREQ 50MG BASE/100MLINJECTABLE / INJECTION1992-01-22b00525d2431f…
2019-09-15 20:21 UTC2019-09N020098-004MIVACRONEQ 10MG BASE/5ML (EQ 2MG BASE/ML)SOLUTION / INTRAVENOUSRLD1992-01-22b00525d2431f…
2019-09-15 20:21 UTC2019-09N020098-005MIVACRONEQ 20MG BASE/10ML (EQ 2MG BASE/ML)SOLUTION / INTRAVENOUSRLD1992-01-22b00525d2431f…
2019-07-19 19:46 UTC2019-07N020098-001MIVACRONEQ 2MG BASE/ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**SOLUTION / INTRAVENOUSRLD1992-01-22ea99ee380514…
2019-07-19 19:46 UTC2019-07N020098-002MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINEREQ 0.5MG BASE/MLINJECTABLE / INJECTION1992-01-22ea99ee380514…
2019-07-19 19:46 UTC2019-07N020098-003MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINEREQ 50MG BASE/100MLINJECTABLE / INJECTION1992-01-22ea99ee380514…
2019-07-19 19:46 UTC2019-07N020098-004MIVACRONEQ 10MG BASE/5ML (EQ 2MG BASE/ML)SOLUTION / INTRAVENOUSRLD1992-01-22ea99ee380514…
2019-07-19 19:46 UTC2019-07N020098-005MIVACRONEQ 20MG BASE/10ML (EQ 2MG BASE/ML)SOLUTION / INTRAVENOUSRLD1992-01-22ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N020098-001MIVACRONEQ 2MG BASE/ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SOLUTION / INTRAVENOUSRLD1992-01-226a51e52b5d6a…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N020098-002MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINEREQ 0.5MG BASE/MLINJECTABLE / INJECTION1992-01-226a51e52b5d6a…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N020098-003MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINEREQ 50MG BASE/100MLINJECTABLE / INJECTION1992-01-226a51e52b5d6a…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N020098-004MIVACRONEQ 10MG BASE/5ML (EQ 2MG BASE/ML)SOLUTION / INTRAVENOUSRLD1992-01-226a51e52b5d6a…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N020098-005MIVACRONEQ 20MG BASE/10ML (EQ 2MG BASE/ML)SOLUTION / INTRAVENOUSRLD1992-01-226a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N020098-001MIVACRONEQ 2MG BASE/ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SOLUTION / INTRAVENOUSRLD1992-01-221c564ffb4f44…
2024-02-18 07:12 UTC2024-02N020098-002MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINEREQ 0.5MG BASE/MLINJECTABLE / INJECTION1992-01-221c564ffb4f44…
2024-02-18 07:12 UTC2024-02N020098-003MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINEREQ 50MG BASE/100MLINJECTABLE / INJECTION1992-01-221c564ffb4f44…
2024-02-18 07:12 UTC2024-02N020098-004MIVACRONEQ 10MG BASE/5ML (EQ 2MG BASE/ML)SOLUTION / INTRAVENOUSRLD1992-01-221c564ffb4f44…
2024-02-18 07:12 UTC2024-02N020098-005MIVACRONEQ 20MG BASE/10ML (EQ 2MG BASE/ML)SOLUTION / INTRAVENOUSRLD1992-01-221c564ffb4f44…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
55044SUPPL2018-07-30
55026SUPPL2018-07-27
12210SUPPL2015-02-03
2016SUPPL2010-11-30
34260SUPPL2010-11-22
34259SUPPL2004-06-09
21148SUPPL2004-06-09
2015SUPPL2002-06-04
41143SUPPL2000-07-03